Business Description
Navana Pharmaceuticals PLC
ISIN : BD0497NAVPH5
Description
Navana Pharmaceuticals PLC operates its business under two divisions namely Veterinary Division and Human Health Division. Veterinary Division manufactures and markets high-quality veterinary medicine and feed supplements for different segments including poultry, dairy and aqua products. Human Health Division operates its manufacturing facilities in strict compliance with WHO cGMP guidelines for the production of tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams and ointments.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.21 | |||||
| 9-Day RSI | 54.39 | |||||
| 14-Day RSI | 52.71 | |||||
| 6-1 Month Momentum % | -58.33 | |||||
| 12-1 Month Momentum % | -49.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.81 | |||||
| Forward Dividend Yield % | 2.81 | |||||
| 5-Year Yield-on-Cost % | 2.81 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Navana Pharmaceuticals PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | |||
| EPS (TTM) (BDT) | 0 | ||
| Beta | 0 | ||
| Volatility % | 40.2 | ||
| 14-Day RSI | 52.71 | ||
| 14-Day ATR (BDT) | 2.906277 | ||
| 20-Day SMA (BDT) | 50.64 | ||
| 12-1 Month Momentum % | -49.87 | ||
| 52-Week Range (BDT) | 36.2 - 118.9 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Navana Pharmaceuticals PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Navana Pharmaceuticals PLC Stock Events
| Event | Date | Price(BDT) | ||
|---|---|---|---|---|
| No Event Data | ||||
Navana Pharmaceuticals PLC Frequently Asked Questions
What is Navana Pharmaceuticals PLC(DHA:NAVANAPHAR)'s stock price today?
The current price of DHA:NAVANAPHAR is BDT51.20. The 52 week high of DHA:NAVANAPHAR is BDT118.90 and 52 week low is BDT36.20.
When is next earnings date of Navana Pharmaceuticals PLC(DHA:NAVANAPHAR)?
The next earnings date of Navana Pharmaceuticals PLC(DHA:NAVANAPHAR) is .
Does Navana Pharmaceuticals PLC(DHA:NAVANAPHAR) pay dividends? If so, how much?
The Dividend Yield %  of Navana Pharmaceuticals PLC(DHA:NAVANAPHAR) is 2.81% (As of Today), Highest Dividend Payout Ratio of Navana Pharmaceuticals PLC(DHA:NAVANAPHAR) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Navana Pharmaceuticals PLC(DHA:NAVANAPHAR) is 2.81%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers